UroGen outlines $5B market opportunity as UGN-102 FDA review nears and commercial launch preparations accelerate
Source link

You May Also Like

4 ways Apple’s transformative ‘product renaissance’ is taking shape

UroGen outlines $5B market opportunity as UGN-102 FDA review nears and commercial launch preparations accelerate
Source link